Document:

exv4w4

Exhibit 4.4

REGISTRATION RIGHTS AGREEMENT

Dated as of September 28, 2009

By and Among

INVERNESS MEDICAL INNOVATIONS, INC.,

the GUARANTORS named herein

and

JEFFERIES & COMPANY, INC.,

GOLDMAN, SACHS & CO.

and

WELLS FARGO SECURITIES, LLC

as Initial Purchasers

7.875% Senior Notes due 2016

 

 

TABLE OF CONTENTS

	 	 	 	 	 
	Section 1. DEFINITIONS
	 	 	2	 
	 
	Section 2. EXCHANGE OFFER
	 	 	5	 
	 
	Section 3. ADDITIONAL INTEREST
	 	 	7	 
	 
	Section 4. REGISTRATION PROCEDURES
	 	 	9	 
	 
	Section 5. REGISTRATION EXPENSES
	 	 	14	 
	 
	Section 6. INDEMNIFICATION
	 	 	15	 
	 
	Section 7. RULES 144 AND 144A
	 	 	18	 
	 
	Section 8. MISCELLANEOUS
	 	 	18	 

 

 

REGISTRATION RIGHTS AGREEMENT

          This Registration Rights Agreement (this “AGREEMENT”) is dated as of September 28, 2009, by
and among INVERNESS MEDICAL INNOVATIONS, INC., a Delaware corporation (the “COMPANY”), and each of
the Guarantors (as defined herein) (the Company and the Guarantors are referred to collectively
herein as the “ISSUERS”), on the one hand, and JEFFERIES & COMPANY, INC., GOLDMAN, SACHS & CO. and
WELLS FARGO SECURITIES, LLC (the “INITIAL PURCHASERS”), on the other hand.

          This Agreement is entered into in connection with the Purchase Agreement, dated as of
September 23, 2009, by and among the Issuers and the Initial Purchasers (the “PURCHASE AGREEMENT”),
relating to the offering of $100,000,000 aggregate principal amount of 7.875% Senior Notes due 2016
of the Company pursuant thereto (including the guarantees thereof by the Guarantors, the “NOTES”).
The execution and delivery of this Agreement is a condition to the Initial Purchasers’ obligation
to purchase the Notes under the Purchase Agreement.

          The parties hereby agree as follows:

     Section 1. DEFINITIONS

          As used in this Agreement, the following terms shall have the following meanings:

          “ACTION” shall have the meaning set forth in Section 6(c) hereof.

          “ADDITIONAL INTEREST” shall have the meaning set forth in Section 3(a) hereof.

          “ADDITIONAL INTEREST PAYMENT DATE” shall have the meaning set forth in Section 3(b) hereof.

          “ADVICE” shall have the meaning set forth in Section 4 hereof.

          “AGREEMENT” shall have the meaning set forth in the first introductory paragraph hereto.

          “APPLICABLE PERIOD” shall have the meaning set forth in Section 2(b) hereof.

          “AUGUST 2009 BASE INDENTURE” shall mean the Indenture, dated as of August 11, 2009, by and
among the Company, as issuer, and The Bank of New York Mellon Trust Company, N.A., as trustee.

          “AUGUST 2009 SENIOR NOTE INDENTURE” shall mean the August 2009 Base Indenture as supplemented
by the August 2009 Senior Note Supplemental Indenture and as may be further supplemented or amended
from time to time in accordance with its terms.

2

 

          “AUGUST 2009 SENIOR NOTE SUPPLEMENTAL INDENTURE” shall mean the First Supplemental Indenture
dated as of August 11, 2009 by and among the Company, as issuer, the Guarantors signatory thereto,
as guarantors, and The Bank of New York Mellon Trust Company, N.A., as trustee, and the Second
Supplemental Indenture dated as of September 22, 2009 by and among the Issuers and The Bank of New
York Mellon Trust Company, N.A.

          “BOARD OF DIRECTORS” shall have the meaning set forth in Section 4 hereof.

          “BUSINESS DAY” shall mean a day that is not a Legal Holiday.

          “COMPANY” shall have the meaning set forth in the introductory paragraph hereto and shall also
include the Company’s successors and assigns.

          “COMMISSION” shall mean the Securities and Exchange Commission.

          “DAY” shall mean a calendar day.

          “EXCHANGE ACT” shall mean the Securities Exchange Act of 1934, as amended, and the rules and
regulations of the Commission promulgated thereunder.

          “EXCHANGE NOTES” shall have the meaning set forth in Section 2(a) hereof.

          “EXCHANGE OFFER” shall have the meaning set forth in Section 2(a) hereof.

          “EXCHANGE OFFER REGISTRATION STATEMENT” shall have the meaning set forth in Section 2(a)
hereof.

          “FREELY TRANSFERABLE” shall mean, with respect to any Note, that if it were not held by an
affiliate (as defined in Rule 405 under the Securities Act) of the Company, it (i) may be resold to
the public in accordance with Rule 144 without volume limitations, (ii) does not bear any
restrictive legends relating to the Securities Act or, solely with respect to Notes in certificated
form, the Holder thereof is entitled to have such legends removed and (iii) does not bear a
restricted CUSIP number.

          “FINRA” shall mean the Financial Industry Regulatory Authority, Inc.

          “GUARANTORS” means each signatory to this Agreement on the date hereof (other than the Company
and the Initial Purchasers), and each Person who executes and delivers a counterpart of this
Agreement hereafter pursuant to Section 8(d) hereof.

          “HOLDER” shall mean any holder of a Note or Notes including any Participating Broker-Dealer
holding a Note or Notes.

          “INDENTURE” shall mean the August 2009 Base Indenture as supplemented by the Third
Supplemental Indenture dated September 28, 2009, by and among the Issuers and The Bank of New York
Mellon Trust Company, N.A., as trustee, pursuant to which the Notes are being issued, as may be
supplemented or amended from time to time in accordance with its terms.

3

 

          “INITIAL PURCHASERS” shall have the meaning set forth in the first introductory paragraph
hereof.

          “INSPECTORS” shall have the meaning set forth in Section 4(j) hereof.

          “ISSUE DATE” shall mean September 28, 2009, the date of issuance of the Notes.

          “ISSUERS” shall have the meaning set forth in the first introductory paragraph hereto.

          “LEGAL HOLIDAY” shall mean a Saturday, a Sunday or a day on which banking institutions in New
York, New York are required by law, regulation or executive order to remain closed.

          “LOSSES” shall have the meaning set forth in Section 6(a) hereof.

          “NOTES” shall have the meaning set forth in the second introductory paragraph hereto.

          “PARTICIPANT” shall have the meaning set forth in Section 6(a) hereof.

          “PARTICIPATING BROKER-DEALER” shall have the meaning set forth in Section 2(b) hereof.

          “PERSON” shall mean an individual, corporation, partnership, joint venture association, joint
stock company, trust, unincorporated limited liability company, government or any agency or
political subdivision thereof or any other entity.

          “PROSPECTUS” shall mean the prospectus included in the Exchange Offer Registration Statement
(including, without limitation, any prospectus subject to completion and a prospectus that includes
any information previously omitted from a prospectus filed as part of an effective registration
statement in reliance upon Rule 430A promulgated under the Securities Act), as amended or
supplemented by any prospectus supplement, and all other amendments and supplements to the
Prospectus, including post-effective amendments, and all material incorporated by reference or
deemed to be incorporated by reference in such Prospectus.

          “PURCHASE AGREEMENT” shall have the meaning set forth in the second introductory paragraph
hereof.

          “RECORDS” shall have the meaning set forth in Section 4(j) hereof.

          “REGISTRATION DEFAULT” shall have the meaning set forth in Section 3(a) hereof.

          “REGISTRATION STATEMENT” shall mean any appropriate registration statement of the Issuers
covering any of the Exchange Notes filed with the Commission under the Securities Act, and all
amendments and supplements to any such Registration Statement,

4

 

including post-effective amendments, in each case including the Prospectus contained therein,
all exhibits thereto and all material incorporated by reference therein.

          “REQUESTING PARTICIPATING BROKER-DEALER” shall have the meaning set forth in Section 2(b)
hereof.

          “RULE 144” shall mean Rule 144 promulgated under the Securities Act, as such Rule may be
amended from time to time, or any similar rule (other than Rule 144A) or regulation hereafter
adopted by the Commission providing for offers and sales of securities made in compliance therewith
resulting in offers and sales by subsequent holders that are not affiliates of an issuer of such
securities being free of the registration and prospectus delivery requirements of the Securities
Act.

          “RULE 144A” shall mean Rule 144A promulgated under the Securities Act, as such Rule may be
amended from time to time, or any similar rule (other than Rule 144) or regulation hereafter
adopted by the Commission.

          “RULE 424(B)” shall mean Rule 424(b) promulgated under the Securities Act, as such Rule may be
amended from time to time.

          “SECURITIES ACT” shall mean the Securities Act of 1933, as amended, and the rules and
regulations of the Commission promulgated thereunder.

          “TIA” shall mean the Trust Indenture Act of 1939, as amended.

          “TRUSTEE” shall mean the trustee under the Indenture and the trustee (if any) under any
indenture governing the Exchange Notes.

     Section 2. EXCHANGE OFFER

          (a) The Issuers shall (i) file a Registration Statement (the “EXCHANGE OFFER REGISTRATION
STATEMENT”) within 150 days after the Issue Date with the Commission on an appropriate registration
form with respect to a registered offer (the “EXCHANGE OFFER”) to exchange any and all of the Notes
for a like aggregate principal amount of notes (including the guarantees with respect thereto, the
“EXCHANGE NOTES”) that are identical in all material respects to the Notes (except that the
Exchange Notes shall not contain terms with respect to transfer restrictions or Additional Interest
upon a Registration Default), (ii) use their commercially reasonable efforts to cause the Exchange
Offer Registration Statement to be declared effective under the Securities Act within 240 days
after the Issue Date and (iii) use their commercially reasonable efforts to consummate the Exchange
Offer within 270 days after the Issue Date. Upon the Exchange Offer Registration Statement being
declared effective by the Commission, the Issuers will offer the Exchange Notes in exchange for
surrender of the Notes. The Issuers shall keep the Exchange Offer open for not less than 30 days
(or longer if required by applicable law) after the date notice of the Exchange Offer is mailed to
Holders. The Issuers shall use their commercially reasonable efforts to issue the Exchange Notes
as “additional notes” under the August 2009 Senior Note Indenture.

5

 

          Each Holder that participates in the Exchange Offer will be required to represent to the
Issuers in writing that (i) any Exchange Notes to be received by it will be acquired in the
ordinary course of its business, (ii) it has no arrangement or understanding with any Person to
participate in the distribution (within the meaning of the Securities Act) of the Exchange Notes in
violation of the provisions of the Securities Act, (iii) it is not an affiliate of the Company or
any Guarantor as defined by Rule 405 of the Securities Act, or if it is an affiliate, it will
comply with the registration and prospectus delivery requirements of the Securities Act to the
extent applicable, (iv) if such Holder is not a broker-dealer, it is not engaged in, and does not
intend to engage in, a distribution of Exchange Notes and (v) if such Holder is a broker-dealer
that will receive Exchange Notes for its own account in exchange for Notes that were acquired as a
result of market-making or other trading activities, it will deliver a prospectus meeting the
requirements of the Securities Act in connection with any resale of such Exchange Notes.

          (b) The Issuers and the Initial Purchasers acknowledge that the staff of the Commission has
taken the position that any broker-dealer that elects to exchange Notes that were acquired by such
broker-dealer for its own account as a result of market-making or other trading activities for
Exchange Notes in the Exchange Offer (a “PARTICIPATING BROKER-DEALER”) may be deemed to be an
“underwriter” within the meaning of the Securities Act and must deliver a prospectus meeting the
requirements of the Securities Act in connection with any resale of such Exchange Notes.

          The Issuers and the Initial Purchasers also acknowledge that the staff of the Commission has
taken the position that if the Prospectus contained in the Exchange Offer Registration Statement
includes a plan of distribution containing a statement to the above effect and the means by which
Participating Broker-Dealers may resell the Exchange Notes, without naming the Participating
Broker-Dealers or specifying the amount of Exchange Notes owned by them, such Prospectus may be
delivered by Participating Broker-Dealers to satisfy their prospectus delivery obligations under
the Securities Act in connection with resales of Exchange Notes for their own accounts (other than
a resale of an unsold allotment resulting from the original offering of the Notes), so long as the
Prospectus otherwise meets the requirements of the Securities Act.

          In light of the foregoing, if requested in writing prior to the expiration of the Exchange
Offer by a Participating Broker-Dealer (a “REQUESTING PARTICIPATING BROKER-DEALER”), the Issuers
agree to use their commercially reasonable efforts to keep the Exchange Offer Registration
Statement continuously effective for a period of 45 days after the date on which the Exchange Offer
Registration Statement is declared effective or, if extended pursuant to the penultimate paragraph
of Section 4 hereof, such longer period (such period, the “APPLICABLE PERIOD”), or such earlier
date as all Requesting Participating Broker-Dealers shall have notified the Company in writing that
such Requesting Participating Broker-Dealers have resold all Exchange Notes acquired in the
Exchange Offer. The Issuers shall include a plan of distribution in such Exchange Offer
Registration Statement that meets the requirements set forth in the preceding paragraph.

          In connection with the Exchange Offer, the Issuers shall:

6

 

     (1) mail or cause to be mailed to each Holder entitled to participate in the
Exchange Offer a copy of the Prospectus forming part of the Exchange Offer
Registration Statement, together with an appropriate letter of transmittal and
related documents;

     (2) utilize the services of a depositary for the Exchange Offer with an address
in the Borough of Manhattan, The City of New York;

     (3) permit Holders to withdraw tendered Notes at any time prior to the 5:00
p.m., New York time, on the last Business Day on which the Exchange Offer shall
remain open; and

     (4) otherwise comply in all material respects with all applicable laws, rules
and regulations.

     As soon as practicable after the close of the Exchange Offer the Company shall:

     (1) accept for exchange all Notes validly tendered and not validly withdrawn by
the Holders pursuant to the Exchange Offer;

     (2) deliver or cause to be delivered to the Trustee for cancellation all Notes
so accepted for exchange; and

     (3) cause the Trustee to authenticate and deliver promptly to each such Holder
Exchange Notes equal in principal amount to the Notes of such Holder so accepted for
exchange.

          The Exchange Offer shall not be subject to any conditions, other than that (i) the Exchange
Offer does not violate applicable law or any applicable interpretation of the staff of the
Commission, (ii) no action or proceeding shall have been instituted or threatened in any court or
by any governmental agency which might materially impair the ability of the Issuers to proceed with
the Exchange Offer and (iii) all governmental approvals shall have been obtained, which approvals
the Company deems necessary for the consummation of the Exchange Offer.

          The Exchange Notes shall be issued under (i) the Indenture or (ii) the August 2009 Senior Note
Indenture (in either case, with such changes as are necessary to comply with any requirements of
the Commission to effect or maintain the qualification thereof under the TIA) and which, in either
case, shall have been qualified under the TIA and shall provide that the Exchange Notes shall not
be subject to the transfer restrictions set forth in the Indenture.

     Section 3. ADDITIONAL INTEREST

          (a) The Issuers and the Initial Purchasers agree that the Holders will suffer damages if the
Issuers fails to fulfill their obligations under Section 2 hereof and that it would not be feasible
to ascertain the extent of such damages with precision. Accordingly, the Issuers agree that if:

7

 

     (i) the Exchange Offer Registration Statement is not filed with the Commission
on or prior to the 150th day following the Issue Date or, if that day is not a
Business Day, the next day that is a Business Day,

     (ii) the Exchange Offer Registration Statement is not declared effective on or
prior to the 240th day following the Issue Date or, if that day is not a Business
Day, the next day that is a Business Day, or

     (iii) the Exchange Offer is not consummated on or prior to the 270th day
following the Issue Date, or, if that day is not a Business Day, the next day that
is a Business Day,

(each such event referred to in clauses (i) through (iii), a “REGISTRATION DEFAULT”), additional
interest in the form of additional cash interest (“ADDITIONAL INTEREST”) will accrue on the Notes.
The rate of Additional Interest will be 0.25% per annum for the first 90-day period immediately
following the occurrence of a Registration Default, increasing by an additional 0.25% per annum
with respect to each subsequent 90-day period up to a maximum amount of Additional Interest of
1.00% per annum, from and including the date on which any such Registration Default shall occur to,
but excluding, the earlier of (1) the date on which all Registration Defaults have been cured or
(2) the date on which all the Notes (other than Notes which constitute an unsold allotment)
otherwise become Freely Transferable without further registration under the Securities Act. If,
after the cure of all Registration Defaults then in effect, there is a subsequent Registration
Default, the rate of Additional Interest for such subsequent Registration Default shall initially
be 0.25% regardless of the rate in effect with respect to any prior Registration Default at the
time of cure of such Registration Default. Upon the expiration of the Applicable Period the
Issuers shall have no further registration obligations.

          Notwithstanding the foregoing, the amount of Additional Interest payable shall not increase
because more than one Registration Default has occurred and is pending.

          (b) Until the earliest of (i) the date no Notes remain outstanding, (ii) the consummation of
the Exchange Offer and (iii) the date on which all the Notes (other than Notes which constitute an
unsold allotment) otherwise become Freely Transferable without further registration under the
Securities Act, the Company shall notify the Trustee within five Business Days after each and every
date on which a Registration Default occurs in respect of which Additional Interest is required to
be paid. Any amounts of Additional Interest due pursuant to clauses (a)(i), (a)(ii) or (a)(iii) of
this Section 3 will be payable in cash semi-annually on each February 15 and August 15 (each a
“ADDITIONAL INTEREST PAYMENT DATE”), commencing with the first such date occurring after any such
Additional Interest commences to accrue, to Holders to whom regular interest is payable on such
Additional Interest Payment Date. The amount of Additional Interest will be determined by
multiplying the applicable rate of Additional Interest by the aggregate principal amount of all
Notes outstanding on the first Additional Interest Payment Date following such Registration Default
in the case of the first such payment of Additional Interest with respect to a Registration Default
(and thereafter at the next succeeding Additional Interest Payment Date until the cure of such
Registration Default), multiplied by a fraction, the numerator of which is the number of days such
Additional Interest rate was applicable during such period (determined on the basis of a 360-day
year comprised of

8

 

twelve 30-day months and, in the case of a partial month, the actual number of days elapsed),
and the denominator of which is 360.

     Section 4. REGISTRATION PROCEDURES

          In connection with the filing of the Exchange Offer Registration Statement pursuant to Section
2 hereof, the Issuers shall effect such registration to permit the exchange or sale of the
securities covered thereby in accordance with the intended method or methods of disposition
thereof, and pursuant thereto and in connection with the Exchange Offer Registration Statement
filed by the Issuers hereunder, the Issuers shall:

          (a) Prepare and file with the Commission the Exchange Offer Registration Statement prescribed
by Section 2 hereof, and use their commercially reasonable efforts to cause such Exchange Offer
Registration Statement to become effective and their commercially reasonable efforts to cause such
Exchange Offer Registration Statement to remain effective as provided herein.

          (b) Prepare and file with the Commission such amendments and post-effective amendments to the
Exchange Offer Registration Statement as may be necessary to keep such Registration Statement
continuously effective for the Applicable Period, and cause the related Prospectus to be
supplemented by any Prospectus supplement required by applicable law, and as so supplemented to be
filed pursuant to Rule 424 (or any similar provisions then in force) promulgated under the
Securities Act.

          (c) If a Prospectus contained in the Exchange Offer Registration Statement filed pursuant to
Section 2 hereof is required under the Securities Act to be delivered by any Participating
Broker-Dealer who seeks to sell Exchange Notes during the Applicable Period and from whom the
Company has received written notice that such Participating Broker-Dealer will be a Participating
Broker-Dealer in the applicable Exchange Offer, notify each such Participating Broker-Dealer and
its counsel (if such counsel is known to the Issuers) as promptly as possible, and, if requested by
any such Person, confirm such notice in writing, (i) when a Prospectus or any Prospectus supplement
or post-effective amendment has been filed, and, with respect to the Exchange Offer Registration
Statement or any post-effective amendment thereto, when the same has become effective under the
Securities Act (including in such notice a written statement that any Requesting Participating
Broker Dealer may, upon request, obtain, at the sole expense of the Issuers, one conformed copy of
the Exchange Offer Registration Statement or post-effective amendment thereto, including financial
statements and schedules, documents incorporated or deemed to be incorporated by reference and
exhibits), (ii) of the issuance by the Commission of any stop order suspending the effectiveness of
the Exchange Offer Registration Statement or of any order preventing or suspending the use of any
Prospectus or the initiation of any proceedings for that purpose, (iii) of the receipt by any of
the Issuers of any notification with respect to the suspension of the qualification or exemption
from qualification of the Exchange Offer or the offer or sale of any of the Exchange Notes in any
jurisdiction, or the initiation or threatening of any proceeding for such purpose, (iv) of the
happening of any event, the existence of any condition or any information becoming known to any
Issuer that makes any statement made in the Exchange Offer Registration Statement or related
Prospectus or any document incorporated or deemed to be incorporated therein by reference untrue in
any material respect or that requires the making of any changes in or amendments or supplements to
the Exchange Offer Registration

9

 

Statement, Prospectus or such documents so that, in the case of the Exchange Offer
Registration Statement, it will not contain any untrue statement of a material fact or omit to
state any material fact required to be stated therein or necessary to make the statements therein
not misleading, and that in the case of the Prospectus, it will not contain any untrue statement of
a material fact or omit to state any material fact required to be stated therein or necessary to
make the statements therein, in the light of the circumstances under which they were made, not
misleading, and (v) of the Company’s determination that a post-effective amendment to the Exchange
Offer Registration Statement would be appropriate.

          (d) If a Prospectus contained in the Exchange Offer Registration Statement filed pursuant to
Section 2 hereof is required under the Securities Act to be delivered by any Participating
Broker-Dealer who seeks to sell Exchange Notes during the Applicable Period, use their commercially
reasonable efforts to prevent the issuance of any order suspending the effectiveness of the
Exchange Offer Registration Statement or of any order preventing or suspending the use of a
Prospectus or suspending the qualification (or exemption from qualification) of the offer or sale
of any of the Exchange Notes in any jurisdiction, and, if any such order is issued, to use their
reasonable best efforts to obtain the withdrawal of any such order at the earliest practicable
moment.

          (e) If a Prospectus contained in the Exchange Offer Registration Statement filed pursuant to
Section 2 hereof is required to be delivered under the Securities Act by any Participating
Broker-Dealer who seeks to sell Exchange Notes during the Applicable Period and if reasonably
requested by any Participating Broker-Dealer, (i) promptly incorporate in such Registration
Statement or Prospectus such information as any Participating Broker-Dealer (based upon advice of
counsel), determines is reasonably necessary to be included therein, provided that the Issuers are
entitled to incorporate such information by means of a prospectus supplement filed pursuant to Rule
424(b) and (ii) make all required filings of such prospectus supplement as soon as practicable
after the Company has received notification of the matters to be incorporated in such prospectus
supplement, provided, however, that the Issuers shall not be required to take any action that
would, in the written opinion of counsel to the Issuers, violate applicable laws.

          (f) If a Prospectus contained in the Exchange Offer Registration Statement filed pursuant to
Section 2 hereof is required under the Securities Act to be delivered by any Participating
Broker-Dealer who seeks to sell Exchange Notes during the Applicable Period, furnish to each such
Participating Broker-Dealer who so requests in writing and their counsel (if such counsel is known
to the Issuers), at the sole expense of the Issuers, one conformed copy of the Exchange Offer
Registration Statement and each post-effective amendment thereto, including financial statements
and schedules, and, if requested, all documents incorporated therein by reference and all exhibits
as soon as reasonably practicable after the filing of such documents with the Commission.

          (g) If a Prospectus contained in the Exchange Offer Registration Statement filed pursuant to
Section 2 hereof is required under the Securities Act to be delivered by any Participating
Broker-Dealer who seeks to sell Exchange Notes during the Applicable Period, deliver to each such
Participating Broker-Dealer and its counsel (if such counsel is known to the Issuers), at the sole
expense of the Issuers, as many copies of the Prospectus or Prospectuses and each amendment or
supplement thereto and any documents incorporated by reference therein as

10

 

such Persons may reasonably request; and, subject to the last paragraph of this Section 4, the
Issuers hereby consent to the use of such Prospectus and each amendment or supplement thereto by
each such Participating Broker-Dealer, in connection with the sale by Participating Broker-Dealers
of the Exchange Notes pursuant to such Prospectus and any amendment or supplement thereto.

          (h) Prior to any public offering of Exchange Notes or any delivery of a Prospectus contained
in the Exchange Offer Registration Statement by any Participating Broker-Dealer who seeks to sell
Exchange Notes during the Applicable Period, use their commercially reasonable efforts to register
or qualify, and to cooperate with each such Participating Broker-Dealer and its counsel in
connection with the registration or qualification (or exemption from such registration or
qualification) of such Exchange Notes for offer and sale under the securities or “blue sky” laws of
such jurisdictions within the United States as any Participating Broker-Dealer reasonably requests
in writing, and to use their commercially reasonable efforts to cause the Issuers’ counsel to
perform “blue sky” investigations and file registrations and qualifications required to be filed
pursuant to this Section 4(h); use their commercially reasonable efforts to keep each such
registration or qualification (or exemption therefrom) effective during the Applicable Period and
do any and all other acts or things reasonably necessary or advisable to enable the disposition in
such jurisdictions of such Exchange Notes covered by the Exchange Offer Registration Statement;
PROVIDED, HOWEVER, that no Issuer shall be required to (A) qualify generally to do business in any
jurisdiction where it is not then so qualified, (B) take any action that would subject it to
general service of process in any such jurisdiction where it is not then so subject or (C) subject
itself to taxation in excess of a nominal dollar amount in any such jurisdiction where it is not
then so subject.

          (i) If a Prospectus contained in the Exchange Offer Registration Statement filed pursuant to
Section 2 hereof is required under the Securities Act to be delivered by any Participating
Broker-Dealer who seeks to sell Exchange Notes during the Applicable Period, upon the occurrence of
any event contemplated by Section 4(c)(iv) or 4(c)(v) hereof, as promptly as practicable prepare
and (subject to the penultimate paragraph of this Section 4) file with the Commission, at the sole
expense of the Issuers, a supplement or post-effective amendment to the Exchange Offer Registration
Statement or a supplement to the related Prospectus or any document incorporated or deemed to be
incorporated therein by reference, or file any other required document so that, as thereafter
delivered to the purchasers of the Exchange Notes to whom such Prospectus will be delivered by a
Participating Broker-Dealer, any such Prospectus will not contain an untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary to make the
statements therein, in the light of the circumstances under which they were made, not misleading.

          (j) Prior to the effective date of the Exchange Offer Registration Statement, (i) provide the
Trustee with certificates for the Exchange Notes in a form eligible for deposit with The Depository
Trust Company and (ii) obtain and provide a CUSIP number for the Exchange Notes. If the Exchange
Notes are issued under the August 2009 Senior Note Indenture, the Company shall use its
commercially reasonable efforts to cause the CUSIP number for the Exchange Notes to be the same as
the CUSIP number provided in respect of the Company’s 7.875% senior notes due 2016 issued on August
11, 2009 pursuant to the August 2009 Senior Note Indenture.

11

 

          (k) If a Prospectus contained in the Exchange Offer Registration Statement filed pursuant to
Section 2 hereof is required under the Securities Act to be delivered by any Participating
Broker-Dealer who seeks to sell Exchange Notes during the Applicable Period, make available for
inspection by each such Participating Broker-Dealer, and any attorney, accountant or other agent
retained by each such Participating Broker-Dealer (collectively, the “INSPECTORS”), at the offices
where normally kept, during reasonable business hours, all financial and other records, pertinent
corporate documents and instruments of the Company and its subsidiaries (collectively, the
“RECORDS”) as shall be reasonably necessary to enable them to exercise any applicable due diligence
responsibilities, and cause the officers, directors and employees of the Company and its
subsidiaries to supply all information reasonably requested by any such Inspector in connection
with such Registration Statement and Prospectus. Prior to receiving access to any Records, each
Inspector shall enter into a written agreement reasonably satisfactory to the Company to the effect
that it will keep the Records and all such information confidential and that it will not, without
the prior written consent of the Company, disclose, or use for any purposes other than in
connection with its due diligence investigation, any Records or any such information that the
Company determines, in good faith, to be confidential and that it notifies the Inspectors in
writing are or is confidential unless (i) the release of such Records or any such information is
ordered pursuant to a subpoena or other order from a court of competent jurisdiction, (ii)
disclosure of such information is necessary or advisable in the opinion of counsel for an Inspector
in connection with any action, claim, suit or proceeding, directly or indirectly, involving such
Inspector and arising out of, based upon, relating to, or involving this Agreement or the Purchase
Agreement, or any transactions contemplated hereby or thereby or arising hereunder or thereunder,
or (iii) the information in such Records or such information has been made generally available to
the public other than as a result of a disclosure or failure to safeguard such information by an
Inspector; provided, however, that (A) each Inspector shall agree to use reasonable best efforts to
provide notice to the Company of the potential disclosure of any information by such Inspector
pursuant to clause (i) or (ii) of this sentence to permit the Issuers to obtain a protective order
(or waive the provisions of this paragraph (k)) and (B) each such Inspector shall take such actions
as are reasonably necessary to protect the confidentiality of such information to the extent such
action is otherwise not inconsistent with, an impairment of or in derogation of the rights and
interests of the Participating Broker-Dealer.

          (l) Provide an indenture trustee for the Exchange Notes and cause the Indenture or the trust
indenture provided for in Section 2(a) hereof to be qualified under the TIA not later than the
effective date of the Exchange Offer; and in connection therewith, cooperate with the trustee under
any such indenture to effect such changes to such indenture as may be required for such indenture
to be so qualified in accordance with the terms of the TIA; and execute, and use their commercially
reasonable efforts to cause such trustee to execute, all documents as may be required to effect
such changes, and all other forms and documents required to be filed with the Commission to enable
such indenture to be so qualified in a timely manner.

          (m) Comply with all applicable rules and regulations of the Commission and make generally
available to the Company’s securityholders an earnings statement satisfying the provisions of
Section 11(a) of the Securities Act and Rule 158 thereunder (or any similar rule promulgated under
the Securities Act) no later than 45 days after the end of any 12-month period (or 90 days after
the end of any 12-month period if such period is a fiscal year), commencing on

12

 

the first day of the first fiscal quarter of the Company after the effective date of the
Exchange Offer Registration Statement, which statement shall cover said 12-month period consistent
with the requirements of Rule 158.

          (n) Upon the written request of a Holder, after consummation of the Exchange Offer, use their
commercially reasonable efforts to obtain an opinion of counsel to the Issuers, in a form customary
for underwritten transactions, addressed to the Trustee for the benefit of all Holders of Notes
participating in the Exchange Offer that the Exchange Notes and the related indenture constitute
legal, valid and binding obligations of the Issuers, enforceable against the Issuers in accordance
with their respective terms, subject to customary exceptions and qualifications.

          (o) If the Exchange Offer is to be consummated, upon delivery of the Notes by Holders to the
Company (or to such other Person as directed by the Company) in exchange for the Exchange Notes,
mark, or cause to be marked, on such Notes that such Notes are being cancelled in exchange for the
Exchange Notes; PROVIDED, HOWEVER, that in no event shall such Notes be marked as paid or otherwise
satisfied.

          (p) Use their commercially reasonable efforts to take all other steps reasonably necessary or
advisable to effect the registration of the Exchange Notes.

          The Company may require each seller of Exchange Notes as to which any registration is being
effected to furnish to the Company such information regarding such seller and the distribution of
such Exchange Notes as the Company may, from time to time, reasonably request. The Company may
exclude from such registration the Exchange Notes of any seller so long as such seller fails to
furnish such information within a reasonable time after receiving such request and in the event of
such an exclusion, the Issuers shall have no further obligation under this Agreement (including,
without limitation, the obligations under Section 3) with respect to such seller or any subsequent
Holder of such Exchange Notes. Each seller of Exchange Notes agrees to furnish promptly to the
Company all information required to be disclosed in order to make any information previously
furnished to the Company by such seller not materially misleading.

          If any such Registration Statement refers to any Holder by name or otherwise as the holder of
any securities of the Company or the Guarantors, then such Registration Statement shall include
language generally to the effect that the holding by such Holder of such securities is not to be
construed as a recommendation by such Holder of the investment quality of the securities covered
thereby and that such holding does not imply that such Holder will assist in meeting any future
financial requirements of the Company or the Guarantors. The Issuers shall not refer by name to
any Holder unless the Issuers reasonably determine, at their sole discretion, that such disclosure
is required.

          Each Participating Broker-Dealer agrees by acquisition of Notes or Exchange Notes that, upon
actual receipt of any notice from the Company (x) of the happening of any event of the kind
described in Section 4(c)(ii), 4(c)(iii), 4(c)(iv) or 4(c)(v) hereof, or (y) that the Board of
Directors of the Company (the “BOARD OF DIRECTORS”) has resolved that the Company has a bona fide
business purpose for doing so, then the Issuers may delay the filing or

13

 

the effectiveness of the Exchange Offer Registration Statement (if not then filed or
effective, as applicable) and shall not be required to maintain the effectiveness thereof or amend
or supplement the Exchange Offer Registration Statement, in all cases, for a period (a “DELAY
PERIOD”) expiring upon the earlier to occur of (i) in the case of the immediately preceding clause
(x), such Participating Broker-Dealer’s receipt of the copies of the supplemented or amended
Prospectus contemplated by Section 4(h) hereof or until it is advised in writing (the “ADVICE”) by
the Company that the use of the applicable Prospectus may be resumed, and has received copies of
any amendments or supplements thereto or (ii) in the case of the immediately preceding clause (y),
the date which is the earlier of (A) the date on which such business purpose ceases to interfere
with the Issuer’s obligations to file or maintain the effectiveness of the Exchange Offer
Registration Statement pursuant to this Agreement or (B) 90 days after the Company notifies the
Participating Broker-Dealers of such good faith determination. There shall not be more than 90 days
of Delay Periods. The Applicable Period shall be extended by the number of days during any Delay
Period. Any Delay Period will not alter the obligations of the Issuers to pay Additional Interest
under the circumstances set forth in Section 3 hereof with respect to any Registration Default.
Each Participating Broker-Dealer agrees by acquisition of Notes or Exchange Notes to keep any
notice and the existence of any Delay Period confidential.

          In the event of any Delay Period pursuant to clause (y) of the preceding paragraph, notice
shall be given as soon as practicable after the Board of Directors makes such a determination of
the need for a Delay Period and shall state, to the extent practicable, an estimate of the duration
of such Delay Period and shall advise the recipient thereof of the agreement of such Holder
provided in the next succeeding sentence. Each Participating Broker-Dealer, by his or its
acceptance of any Exchange Note, agrees that during any Delay Period, each Participating
Broker-Dealer will discontinue disposition of such Exchange Notes covered by such Registration
Statement or Prospectus.

     Section 5. REGISTRATION EXPENSES

          All fees and expenses incident to the Issuer’s performance of or compliance with this
Agreement (other than any discounts or commissions) shall be borne by the Issuers, whether or not
the Exchange Offer Registration Statement is filed or becomes effective or the Exchange Offer is
consummated, including, without limitation, (i) all registration and filing fees (including,
without limitation, fees and expenses of compliance with state securities or “blue sky” laws
(including, without limitation, fees and disbursements of counsel in connection with “blue sky”
qualifications of the Exchange Notes and determination of the eligibility of the Exchange Notes for
investment under the laws of such jurisdictions (x) where the holders of Notes are located, in the
case of an Exchange Offer, or (y) as provided in Section 4(h) hereof, in the case of Exchange Notes
to be sold by a Participating Broker-Dealer during the Applicable Period)), (ii) printing expenses,
including, without limitation, expenses of printing certificates for Exchange Notes in a form
eligible for deposit with The Depository Trust Company and of printing prospectuses if the printing
of prospectuses is requested in respect of Exchange Notes to be sold by any Participating
Broker-Dealer during the Applicable Period, (iii) messenger, telephone and delivery expenses, (iv)
fees and disbursements of counsel for the Issuers, (v) fees and disbursements of all independent
certified public accountants of the Issuers, (vi) Securities Act liability insurance, if the
Issuers desires such insurance, (vii) fees and expenses of all other Persons retained by any of the
Issuers, (viii) internal expenses of the Issuers (including, without

14

 

limitation, all salaries and expenses of officers and employees of the Company performing
legal or accounting duties), (ix) the expense of any annual audit, (x) the fees and expenses
incurred in connection with the listing of the securities to be registered on any securities
exchange, and the obtaining of a rating of the securities, in each case, if applicable, (xi) any
required fees and expenses incurred in connection with any filing required to be made with FINRA,
and (xii) the expenses relating to printing, word processing and distributing the Exchange Offer
Registration Statement and any other documents necessary in order for the Issuers to comply with
their obligations under this Agreement. Notwithstanding the foregoing or anything to the contrary
in this Agreement, each Participating Broker-Dealer shall pay all discounts and commissions with
respect to any sale of Exchange Notes by or on behalf of it.

     Section 6. INDEMNIFICATION

          (a) Each Issuer, jointly and severally, agrees to indemnify and hold harmless each Holder of
Notes and Participating Broker-Dealer selling Exchange Notes during the Applicable Period, each
Person, if any, who controls any such Person within the meaning of Section 15 of the Securities Act
or Section 20(a) of the Exchange Act, the agents, employees, officers and directors of each Holder
and each such Participating Broker-Dealer and the agents, employees, officers and directors of any
such controlling Person (each, a “PARTICIPANT”) from and against any and all losses, liabilities,
claims, damages and expenses (including, but not limited to, reasonable attorneys’ fees and any and
all reasonable out-of-pocket expenses actually incurred in investigating, preparing or defending
against any litigation, commenced or threatened, or any claim whatsoever, and any and all
reasonable amounts paid in settlement of any claim or litigation (in the manner set forth in clause
(c) below)) (collectively, “LOSSES”) to which they or any of them may become subject under the
Securities Act, the Exchange Act or otherwise insofar as such Losses (or actions in respect
thereof) arise out of or are based upon any untrue statement or alleged untrue statement of a
material fact contained in the Exchange Offer Registration Statement (or any amendment thereto) or
Prospectus (as amended or supplemented if the Company shall have furnished any amendments or
supplements thereto) or any preliminary prospectus, or caused by, arising out of or based upon any
omission or alleged omission to state therein a material fact required to be stated therein or
necessary to make the statements therein, in the case of the Prospectus, in the light of the
circumstances under which they were made, not misleading, PROVIDED, HOWEVER, that (i) the foregoing
indemnity shall not be available to any Participant insofar as such Losses are caused by any untrue
statement or omission or alleged untrue statement or omission made in reliance upon and in
conformity with information relating to such Participant furnished to the Company in writing by or
on behalf of such Participant expressly for use therein, and (ii) the foregoing indemnity with
respect to any preliminary prospectus shall not inure to the benefit of any Participant from whom
the Person asserting such Losses purchased Exchange Notes if (x) it is established in the related
proceeding that such Participant failed to send or give a copy of the Prospectus (as amended or
supplemented if such amendment or supplement was furnished to such Participant prior to the written
confirmation of such sale) to such Person with or prior to the written confirmation of such sale,
if required by applicable law, and (y) the untrue statement or omission or alleged untrue statement
or omission was corrected in the Prospectus (as amended or supplemented if amended or supplemented
as aforesaid) and such Prospectus does not contain any other untrue statement or omission or
alleged untrue statement or omission that was the subject matter of the related proceeding. This

15

 

indemnity agreement will be in addition to, but not in duplication of, any liability that the
Issuers may otherwise have to a Participant, including, but not limited to, liability under this
Agreement.

          (b) Each Participant agrees, severally and not jointly, to indemnify and hold harmless each
Issuer, each Person, if any, who controls any Issuer within the meaning of Section 15 of the
Securities Act or Section 20(a) of the Exchange Act, and each of their respective agents,
employees, officers and directors and the agents, employees, officers and directors of any such
controlling Person from and against any Losses to which they or any of them may become subject
under the Securities Act, the Exchange Act or otherwise insofar as such Losses (or actions in
respect thereof) arise out of or are based upon any untrue statement or alleged untrue statement of
a material fact contained in the Exchange Offer Registration Statement (or any amendment thereto)
or Prospectus (as amended or supplemented if the Company shall have furnished any amendments or
supplements thereto) or any preliminary prospectus, or caused by, arising out of or based upon any
omission or alleged omission to state therein a material fact required to be stated therein or
necessary to make the statements therein, in the case of the Prospectus, in the light of the
circumstances under which they were made, not misleading, in each case to the extent, but only to
the extent, that any such Loss arises out of or is based upon any untrue statement or alleged
untrue statement or omission or alleged omission made in reliance upon and in conformity with
information relating to such Participant furnished in writing to the Company by or on behalf of
such Participant expressly for use therein. This indemnity agreement shall be in addition to, but
not in duplication of, any liability that the Participants may otherwise have to an Issuer,
including, but not limited to, liability under this Agreement.

          (c) Promptly after receipt by an indemnified party under subsection 6(a) or 6(b) above of
notice of the commencement of any action, suit or proceeding (collectively, an “ACTION”), such
indemnified party shall, if a claim in respect thereof is to be made against the indemnifying party
under such subsection, notify each party against whom indemnification is to be sought in writing of
the commencement of such action (but the failure so to notify an indemnifying party shall not
relieve such indemnifying party from any liability that it may have under this Section 6 except to
the extent that it has been prejudiced in any material respect by such failure). In case any such
action is brought against any indemnified party, and it notifies an indemnifying party of the
commencement of such action, the indemnifying party will be entitled to participate in such action,
and to the extent it may elect by written notice delivered to the indemnified party promptly after
receiving the aforesaid notice from such indemnified party, to assume the defense of such action
with counsel reasonably satisfactory to such indemnified party. Notwithstanding the foregoing, the
indemnified party or parties shall have the right to employ its or their own counsel in any such
action, but the reasonable fees and expenses of such counsel shall be at the expense of such
indemnified party or parties unless (i) the employment of such counsel shall have been authorized
in writing by the indemnifying parties in connection with the defense of such action, (ii) the
indemnifying parties shall not have employed counsel to take charge of the defense of such action
within a reasonable time after notice of commencement of the action, or (iii) the named parties to
such action (including any impleaded parties) include such indemnified party and the indemnifying
party or parties (or such indemnifying parties have assumed the defense of such action), and such
indemnified party or parties shall have reasonably concluded, after consultation with counsel, that
there may be defenses available to it or them that are different from or additional to those
available to one or all of the indemnifying parties (in

16

 

which case the indemnifying parties shall not have the right to direct the defense of such
action on behalf of the indemnified party or parties), in any of which events such reasonable fees
and expenses of counsel shall be borne by the indemnifying parties. In no event shall the
indemnifying party be liable for the reasonable fees and expenses of more than one counsel
(together with appropriate local counsel) at any time for all indemnified parties in connection
with any one action or separate but substantially similar or related actions arising in the same
jurisdiction out of the same general allegations or circumstances. Any such separate firm for the
Participants shall be designated in writing by Participants who sold a majority in interest of (i)
Notes with respect to which Participants experienced potential Losses and (ii) Exchange Notes sold
by all such Participants who experienced potential Losses and shall be reasonably acceptable to the
Company, and any such separate firm for the Issuers, each control Person of the Issuers and their
respective affiliates, officers, directors, representatives, employees and agents shall be
designated in writing by the Company, and shall be reasonably acceptable to a majority in interest
of the indemnifying parties. An indemnifying party shall not be liable for any settlement of any
claim or action effected without its written consent, which consent may not be unreasonably
withheld. No indemnifying party shall, without the prior written consent of the indemnified party,
effect any settlement of any pending or threatened proceeding in respect of which any indemnified
party is or could have been a party and indemnity could have been sought hereunder by such
indemnified party, unless such settlement includes an unconditional release of such indemnified
party from all liability on claims that are the subject matter of such proceeding.

          (d) In order to provide for contribution in circumstances in which the indemnification
provided for in this Section 6 is for any reason held to be unavailable from the indemnifying
party, or is insufficient to hold harmless a party indemnified under this Section 6, each
indemnifying party shall contribute to the amount paid or payable by such indemnified party as a
result of such aggregate Losses (i) in such proportion as is appropriate to reflect the relative
benefits received by each indemnifying party, on the one hand, and each indemnified party, on the
other hand, from the sale of the Notes to the Initial Purchasers or the resale of the Exchange
Notes by such Holder, as applicable, or (ii) if such allocation is not permitted by applicable law,
in such proportion as is appropriate to reflect not only the relative benefits referred to in
clause (i) above but also the relative fault of each indemnified party, on the one hand, and each
indemnifying party, on the other hand, in connection with the statements or omissions that resulted
in such Losses, as well as any other relevant equitable considerations. The benefits received by
the Issuers shall be deemed to be the total proceeds from the sale of the Notes to the Initial
Purchasers (net of discounts and commissions but before deducting expenses) received by the
Issuers. The relative fault of the parties shall be determined by reference to, among other things,
whether the untrue or alleged untrue statement of a material fact or the omission or alleged
omission to state a material fact relates to information supplied by the Issuers or such
Participant and the parties’ relative intent, knowledge, access to information and opportunity to
correct or prevent such statement or omission or alleged statement or omission.

          (e) The parties agree that it would not be just and equitable if contribution pursuant to this
Section 6 were determined by pro rata allocation or by any other method of allocation that does not
take into account the equitable considerations referred to above. Notwithstanding the provisions of
this Section 6, (i) in no case shall any Participant be required to contribute any amount in excess
of the amount by which the net proceeds received by such Participant in connection with the sale of
the Exchange Notes exceeds the amount of any

17

 

damages that such Participant has otherwise been required to pay by reason of any untrue or
alleged untrue statement or omission or alleged omission and (ii) no person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to
contribution from any person who was not guilty of such fraudulent misrepresentation. Any party
entitled to contribution will, promptly after receipt of notice of commencement of any action
against such party in respect of which a claim for contribution may be made against another party
or parties under this Section 6, notify such party or parties from whom contribution may be sought,
but the omission to so notify such party or parties shall not relieve the party or parties from
whom contribution may be sought from any obligation it or they may have under this Section 6 or
otherwise, except to the extent that it has been prejudiced in any material respect by such
failure; PROVIDED, HOWEVER, that no additional notice shall be required with respect to any action
for which notice has been given under this Section 6 for purposes of indemnification. Anything in
this Section to the contrary notwithstanding, no party shall be liable for contribution with
respect to any action or claim settled without its written consent; PROVIDED, HOWEVER, that such
written consent was not unreasonably withheld.

     Section 7. RULES 144 AND 144A

          The Issuers covenant that they will file the reports required, if any, to be filed by them
under the Securities Act and the Exchange Act in a timely manner in accordance with the
requirements of the Securities Act and the Exchange Act and, if at any time the Issuers are not
required to file such reports, they will, upon the request of any Holder or beneficial owner of
Notes, make available such information as required by, and so long as necessary to permit sales of
the Notes pursuant to, Rule 144A under the Securities Act. The Issuers further covenant that for so
long as any Notes remain outstanding they will take such further action as any Holder of Notes may
reasonably request from time to time to enable such Holder to sell Notes without registration under
the Securities Act within the limitation of the exemptions provided by (a) Rule 144 and Rule 144A
under the Securities Act, as such Rules may be amended from time to time, or (b) any similar rule
or regulation hereafter adopted by the Commission.

     Section 8. MISCELLANEOUS

          (a) NO INCONSISTENT AGREEMENTS. The Issuers have not, as of the date hereof, and shall not, after
the date of this Agreement, enter into any agreement with respect to any of their securities that
is inconsistent with the rights granted to the Holders of Notes in this Agreement or otherwise
conflicts with the provisions hereof. The rights granted to the Holders hereunder do not conflict
with and are not inconsistent with, in any material respect, the rights granted to the holders of
any of the Issuers’ other issued and outstanding securities under any such agreements.

          (b) AMENDMENTS AND WAIVERS. The provisions of this Agreement may not be amended, modified or
supplemented, and waivers or consents to departures from the provisions hereof may not be given
except pursuant to a written agreement duly signed and delivered by (i) the Company (on behalf of
all Issuers) and (ii)(A) the Holders of not less than a majority in aggregate principal amount of
the then outstanding Notes and (B) in circumstances that would adversely affect the Participating
Broker-Dealers, Participating Broker-Dealers holding not less than a majority in aggregate
principal amount of the Exchange Notes held by all

18

 

Participating Broker-Dealers; provided, however, that Section 6 and this Section 8(b) may not
be amended, modified or supplemented except pursuant to a written agreement duly signed and
delivered by the Issuers and each Holder of Notes affected by any such amendment, modification,
waiver or supplement and each Participating Broker-Dealer (including any Person who was a
Participating Broker-Dealer holding Exchange Notes disposed of pursuant to the Exchange Offer
Registration Statement) affected by any such amendment, modification, waiver or supplement.
Notwithstanding the foregoing, a waiver or consent to depart from the provisions hereof with
respect to a matter that relates exclusively to the rights of Participating Broker-Dealers whose
Exchange Notes are being sold pursuant to the Exchange Offer Registration Statement and that does
not directly or indirectly affect, impair, limit or compromise the rights of other Holders of Notes
or Exchange Notes may be given by Participating Broker-Dealers holding at least a majority in
aggregate principal amount of the Exchange Notes being sold pursuant to the Exchange Offer
Registration Statement.

          (c) NOTICES. All notices and other communications (including, without limitation, any notices or
other communications to the Trustee) provided for or permitted hereunder shall be made in writing
by hand-delivery, registered first-class mail, next-day air courier or telecopier:

      (i) if to a Holder of Notes or any Participating Broker-Dealer, at the most current
address of such person set forth on the records of the registrar under the Indenture or the
August 2009 Indenture, as applicable.

          (ii) if to any Issuer, to it at:

c/o Inverness Medical Innovations, Inc.

51 Sawyer Road, Suite 200

Waltham, MA 02453

Fax Number: (781) 647-3939

Attention: Chief Financial Officer

with a copy to:

Foley Hoag LLP

155 Seaport Boulevard

Boston, Massachusetts 02210

Facsimile: (617) 832-7000

Attention: John D. Hancock, Esq.

          (iii) if to the Initial Purchasers, at the address as follows:

Jefferies & Company, Inc.

520 Madison Avenue

New York, New York 10022

Facsimile: (212) 284-2280

Attention: General Counsel

19

 

          All such notices and communications shall be deemed to have been duly given: when delivered by
hand, if personally delivered; five Business Days after being deposited in the
mail, postage prepaid, if mailed; when receipt is acknowledged by the recipient’s telecopier
machine, if telecopied; and on the next Business Day, if timely delivered to an air courier
guaranteeing overnight delivery.

          Copies of all such notices, demands or other communications shall be concurrently delivered by
the Person giving the same to the Trustee at the address and in the manner specified in such
Indenture.

          (d) GUARANTORS. Until the Notes (other than unsold allotments of the Initial Purchasers) are
Freely Transferable, the Issuers shall cause each Person that becomes a guarantor of the Notes
under the Indenture to execute and deliver a counterpart to this Agreement which subjects such
Person to the provisions of this Agreement as a Guarantor. Each of the Guarantors agrees to join
the Issuers in all of their undertakings hereunder to effect the Exchange Offer for the Exchange
Notes.

          (e) SUCCESSORS AND ASSIGNS. This Agreement shall inure to the benefit of and be binding upon the
successors and assigns of each of the parties hereto, the Holders and the Participating
Broker-Dealers; PROVIDED, HOWEVER, that this Agreement shall not inure to the benefit of or be
binding upon a successor or assign of a Holder unless and to the extent such successor or assign
holds Notes.

          (f) COUNTERPARTS. This Agreement may be executed in any number of counterparts and by the parties
hereto in separate counterparts, each of which when so executed shall be deemed to be an original
and all of which taken together shall constitute one and the same agreement.

          (g) HEADINGS. The headings in this Agreement are for convenience of reference only and shall not
limit or otherwise affect the meaning hereof.

          (h) GOVERNING LAW. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS
OF THE STATE OF NEW YORK, AS APPLIED TO CONTRACTS MADE AND PERFORMED WHOLLY WITHIN THE STATE OF NEW
YORK, WITHOUT REGARD TO PRINCIPLES OF CONFLICTS OF LAW.

          (i) SEVERABILITY. If any term, provision, covenant or restriction of this Agreement is held by a
court of competent jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the
terms, provisions, covenants and restrictions set forth herein shall remain in full force and
effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use
their reasonable best efforts to find and employ an alternative means to achieve the same or
substantially the same result as that contemplated by such term, provision, covenant or
restriction. It is hereby stipulated and declared to be the intention of the parties that they
would have executed the remaining terms, provisions, covenants and restrictions without including
any of such that may be hereafter declared invalid, illegal, void or unenforceable.

20

 

          (j) SECURITIES HELD BY THE ISSUERS OR THEIR AFFILIATES. Whenever the consent or approval of
Holders of a specified percentage of Notes is required hereunder, Notes held by the Issuers or any
of their affiliates (as such term is defined in Rule 405 under the
Securities Act) shall not be deemed outstanding and shall not be counted in determining
whether such consent or approval was given by the Holders of such required percentage.

          (k) THIRD-PARTY BENEFICIARIES. Holders and beneficial owners of Notes and Participating
Broker-Dealers are intended third-party beneficiaries of this Agreement, and this Agreement may be
enforced by such Persons. No other Person is intended to be, or shall be construed as, a
third-party beneficiary of this Agreement.

          (l) ATTORNEYS’ FEES. As between the parties to this Agreement, in any action or proceeding
brought to enforce any provision of this Agreement, or where any provision hereof is validly
asserted as a defense, the successful party shall be entitled to recover reasonable attorneys’ fees
actually incurred in addition to its reasonable costs and expenses and any other available remedy.

          (m) ENTIRE AGREEMENT. This Agreement, together with the Purchase Agreement and the Indenture, is
intended by the parties as a final and exclusive statement of the agreement and understanding of
the parties hereto in respect of the subject matter contained herein and therein and any and all
prior oral or written agreements, representations, or warranties, contracts, understandings,
correspondence, conversations and memoranda between the Holders on the one hand and the Issuers on
the other, or between or among any agents, representatives, parents, subsidiaries, affiliates,
predecessors in interest or successors in interest with respect to the subject matter hereof and
thereof are merged herein and replaced hereby.

21

 

          IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written
above.

	 	 	 	 	 	 	 
	 	 	INVERNESS MEDICAL INNOVATIONS, INC.	 	 
	 
	 	 	 	 	 	 
	 

	 	By:

Name:
	 	/s/ David A. Teitel
 

David A. Teitel
	 	 
	 

	 	Title:
	 	Chief Financial Officer and Treasurer	 	 

22

 

	 	 	 
	 

	 	EXISTING GUARANTORS:
	 
	 	 
	 

	 	ADVANTAGE DIAGNOSTICS CORPORATION
	 

	 	ALERE CDM LLC
	 

	 	ALERE LLC
	 

	 	ALERE HEALTHCARE OF ILLINOIS, INC.
	 

	 	ALERE HEALTH IMPROVEMENT COMPANY
	 

	 	ALERE HEALTH SYSTEMS, INC.
	 

	 	ALERE MEDICAL, INC.
	 

	 	ALERE WELLOLOGY, INC.
	 

	 	ALERE WOMEN’S AND CHILDREN’S HEALTH, LLC
	 

	 	AMEDITECH INC.
	 

	 	APPLIED BIOTECH, INC.
	 

	 	BINAX, INC.
	 

	 	BIOSITE INCORPORATED
	 

	 	CHOLESTECH CORPORATION
	 

	 	FIRST CHECK DIAGNOSTICS CORP.
	 

	 	FIRST CHECK ECOM, INC.
	 

	 	GENECARE MEDICAL GENETICS CENTER, INC.
	 

	 	HEMOSENSE, INC.
	 

	 	IM US HOLDINGS, LLC

	 	 	 	 	 
	 	 	 
	 	By:  	                                              /s/ David A. Teitel
 	 
	 	 	Name:  	David A. Teitel 	 
	 	 	Title (respectively):  Vice President; Vice
President, Finance; Vice President and
Treasurer; Vice President, Finance; Vice
President, Finance; Vice President and
Treasurer; Vice President and Treasurer;
Vice President, Finance; Vice President,
Finance; General Manager; Vice President;
Vice President, Finance; Vice President,
Finance; Vice President, Finance and Chief
Financial Officer; Vice President, Finance;
Vice President; Vice President and
Treasurer; Treasurer; President 	 

23

 

	 	 	 	 	 

	 	 	 
	 

	 	EXISTING GUARANTORS (continued):
	 

	 	INNOVACON, INC.
	 

	 	INNOVATIONS RESEARCH, LLC
	 

	 	INNOVATIVE MOBILITY, LLC
	 

	 	INSTANT TECHNOLOGIES, INC.
	 

	 	INVERNESS MEDICAL, LLC
	 

	 	INVERNESS MEDICAL — BIOSTAR INC.
	 

	 	INVERNESS MEDICAL INNOVATIONS NORTH AMERICA, INC.
	 

	 	INVERNESS MEDICAL INTERNATIONAL HOLDING CORP.
	 

	 	ISCHEMIA TECHNOLOGIES, INC.
	 

	 	IVC INDUSTRIES, INC.
	 

	 	MATRITECH, INC.
	 

	 	OSTEX INTERNATIONAL, INC.
	 

	 	QUALITY ASSURED SERVICES, INC.
	 

	 	REDWOOD TOXICOLOGY LABORATORY, INC.
	 

	 	RTL HOLDINGS, INC.
	 

	 	SELFCARE TECHNOLOGY, INC.
	 

	 	WAMPOLE LABORATORIES, LLC
	 

	 	ZYCARE, INC.

	 	 	 	 	 
	 	 	 
	 	By:  	                                              /s/ David A. Teitel
 	 
	 	 	Name:  	David A. Teitel 	 
	 	 	Title (respectively):  Vice President, Finance;
Vice President, Finance; Chief Financial
Officer; Vice President, Finance; Vice
President, Finance; Vice President, Finance;
Vice President, Finance; President; Vice
President, Finance; Vice President; Vice
President, Finance; Vice President, Finance;
Chief Financial Officer; Vice President,
Finance; Vice President, Finance; Vice
President, Finance; Vice President; Chief
Financing Officer and Treasurer 	 

24

 

	 	 	 	 	 

	 	 	 	 	 
	 	EXISTING GUARANTORS (continued):

MATRIA OF NEW YORK, INC.

 	 
	 	By:  	                                                   /s/ Tom Underwood
 	 
	 	 	Name:  	Tom Underwood 	 
	 	 	Title:  	President 	 

25

 

	 	 	 	 	 

Confirmed and Accepted as of

the date first above written:

	 	 	 	 	 
	JEFFERIES & COMPANY, INC.	 	 
	 
	 	 	 	 
	By:

	 	/s/ Craig Zaph
 

Name: Craig Zaph
	 	 
	 

	 	Title: Managing Director	 	 
	 
	 	 	 	 
	GOLDMAN, SACHS & CO.	 	 
	 
	 	 	 	 
	By:

	 	/s/ Goldman, Sachs & Co.
 

(Goldman, Sachs & Co.)
	 	 
	 
	 	 	 	 
	WELLS FARGO SECURITIES, LLC	 	 
	 
	 	 	 	 
	By:

	 	/s/ David Gillespie
 

Name: David Gillespie
	 	 
	 

	 	Title: Managing Director	 	 

26Exhibit 10.4

Exhibit 10.4

EMPLOYMENT AGREEMENT

This Employment Agreement (this “Agreement”) is made as of this 5th day of January,
2009 (“Effective Date”), by and between Veritec, Inc., a Nevada Corporation having its principal
offices at 2445 Winnetka Ave. N., Suite #201, Golden Valley, Minnesota 55427 (hereinafter,
“Veritec”), and Jeffrey Hattara, an individual (hereinafter, “Employee”).

Veritec and Employee are sometimes individually referred to herein as “Party” and sometimes
collectively referred to herein as “The Parties”.

WHEREAS, Veritec is engaged in the business of designing, developing, marketing and licensing
its proprietary matrix symbol multi-dimensional bar code data storage technology for use in a
variety of industries such as banking, electronic media, manufacturing automation and biometric
identification; and

WHEREAS, The Parties intend by this Agreement to define an employer-employee relationship on
the terms and subject to the conditions set forth herein and intend that this Agreement shall
establish a basis of their relationship and define their respective rights, duties and obligations.

NOW THEREFORE, in consideration of the mutual promises, covenants, warranties and agreements
set forth herein, The Parties agree as follows:

I.

Definitions

As used in this Agreement, each of the following words and terms shall have the following meaning:

“Competitive Business” means directly or indirectly designing, developing, making,
promoting, offering, soliciting, selling, leasing, licensing, transferring or otherwise making
Competitive Products available to third parties.

“Competitive Products” mean single or multi-dimensional bar code products and processes (as
well as services related thereto) manufactured or sold by anyone other than Veritec that are used
in competition with Veritec Products in any industry.

“Confidential Information” means any information that is not generally known to or readily
available to other persons or entities by ordinary means. Confidential Information includes
information of any nature which would have economic value, including but not be limited to:
algorithms, compilations, devices, formulas, images, methods, patterns, processes, programs,
specifications, source codes, techniques, financial forecasts or results, sales forecasts or
results, marketing plans or strategies, strategic plans, new products, information related to
existing our prospective customers and suppliers, including customer and supplier lists.
Confidential Information also includes any trade secrets as defined in Minnesota’s Uniform
Trade Secrets Act codified as Minn. Stat. § 325C.01 et seq. “Confidential Information” shall
not include any information which (a) the recipient can prove that at the time of disclosure
was published or otherwise in the public domain; (b) at the time of disclosure became part of
the public domain through means other than a breach of this Agreement by the recipient;
(c) the recipient can
substantiate by documentary evidence was known to the recipient prior to its receipt from the
provider; or (d) was or is independently developed by the recipient without the utilization of any
Confidential Information supplied by the provider. Additionally, a recipient hereunder shall not
be deemed to have disclosed Confidential Information in violation of this Agreement if, and then
only to the extent that, the recipient can demonstrate by clear and convincing evidence that the
recipient was required to make such disclosure pursuant to any applicable law, regulation or
governmental order, or pursuant to any judgment, order, decree or award of a court of competent
jurisdiction, and the recipient provided the provider with at least thirty (30) days written notice
(or if the circumstances do not permit such advance written notice, such advance notice as is
reasonably practicable under the circumstances) prior to making such disclosure.

 

Page 1

Employment Agreement — Jeffrey Hattara

 

“Inventions”
and “Works of Authorship”: “Inventions” means all new concepts, ideas and
discoveries of novel things and uses associated with, or for use with Veritec Products, as
well as, all concepts, ideas and discoveries of improvements to Veritec Products from whatever
source derived (whether or not patentable). “Works of Authorship” means all writings,
drawings, images, brochures, presentations, videos and “white papers” whether printed or in
electronic formats, software and software source code from whatever source derived (whether or
not copyrightable), including all modifications and derivative works based thereon. These
terms shall include all forms of original expression fixed in any tangible medium, created in
the past at the request of Veritec, or created hereafter by anyone at the request of Veritec,
or created by Employee individually or in concert with others that relate in any manner to the
present or prospective business of Veritec if learned, or was conceived by Employee or those
employed or retained by Employee during the course and scope of his employment. All such
Inventions and Works of Authorship are hereby deemed to be the sole and separate property of
Veritec.

NOTICE — The parties understand that Inventions and Works of Authorship do not include
an invention for which no equipment, supplies, facility, or trade secret information of Veritec was
used and which was developed entirely on the Employee’s own time, and (1) which does not relate
(a)directly to the business of Veritec, including the Veritec Products, or (b) to Veritec’s actual
or demonstrably anticipated research or development, or (2) which does not result from any work
performed by the Employee for Veritec.

“Veritec” means Veritec, Inc. and its subsidiaries whether existing or hereafter formed and
any successors in interest of the same.

“Veritec Customers” mean persons, governmental or commercial entities that purchase Veritec
Products. Veritec’s customer lists are and always shall be the property of Veritec.

“Veritec Products” mean: (i) the matrix symbol multi-dimensional bar code data storage
technology, together with the technology and know-how for application thereof to any substrate, the
design, use and application of hardware and software for the encoding and decoding thereof for
retrieval of data, and (ii) the banking software platform used in the processing and managing of
financial cards; all as presently designed, developed, invented, written or owned by Veritec, or
hereafter designed, developed, invented, written or owned by or for Veritec.

“Vesting Date(s)” mean that date or those dates on which Employee’s restricted stock and
options to purchase common stock vest.

 

Page 2

Employment Agreement — Jeffrey Hattara

 

II.

Duties, Obligations and Rights of The Parties

2.01. Position of Employment — Title — Supervision. Veritec hereby offers to employ and
Employee hereby accepts employment together with the duties and responsibilities associated with
being Veritec’s President and Chief Executive Officer. Employee shall be subject to general
supervision, advice and direction of the Board of Directors and any Committees of the Board of
Directors of Veritec.

2.02. Best Efforts — Duties of Employee. Employee agrees to perform faithfully,
industriously, and to the best of Employee’s ability, experience and talents all of the duties that
may be reasonably requested by Veritec.

2.03. Compensation to Employee. In order to induce Employee to accept the offer of
employment subject to the express terms and conditions set forth herein, Veritec hereby promises,
covenants, warrants and agrees to pay Employee the following forms and amounts of compensation:

	(a)	 	Base Salary. As a base salary, the sum of Twelve and NO/100 U.S. Dollars ($12.00) per annum
paid on a monthly basis, less applicable federal and state taxes and deductions, to be paid in
accordance with Veritec’s standard payroll procedures, commencing on Employee’s first day of
employment with Veritec which is the Effective Date. Employee’s base salary shall be reviewed
on an annual basis.

	(b)	 	Restricted Stock. As authorized by Veritec’s Board of Directors during its December 5, 2008
special meeting, Employee is hereby granted One Million (1,000,000) shares of Veritec
restricted stock at a price of thirty U.S. cents ($0.30) per share (the closing market price
of the shares on the date of the grant) with the following vesting schedule: (i) Five Hundred
Thousand (500,000) shares shall vest on that date that is six (6) months after the Effective
Date, and (ii) the remaining Five Hundred Thousand (500,000) shares shall vest on that date
that is twelve (12) months after the Effective Date. Each anniversary year, Employee may
receive additional shares of Veritec restricted stock as may be determined by Veritec’s Board
of Directors and accepted by Employee.

	(c)	 	Stock Options. As authorized by Veritec’s Board of Directors during its December 5, 2008
special meeting, Employee is hereby granted non-qualified options to purchase One Hundred
Fifty Thousand (150,000) shares of Veritec common stock (OTC: “VRTC”) at a price of thirty
U.S. cents ($0.30) per share. The options granted herein shall fully vest on that date that
is twelve (12) months after the Effective Date. Each anniversary year, Employee may receive
additional options to purchase shares of Veritec common stock as may be determined by
Veritec’s Board of Directors.

	(d)	 	The Restricted Stock and Stock Options shall be governed by Restricted Stock Agreements and
Stock Option Agreements executed by the Parties, in the forms attached hereto as Exhibit A and
Exhibit B, respectively.

	(e)	 	Medical Insurance. Veritec shall pay its standard portion of the cost of medical insurance
for Employee and insurable dependents of Employee through Veritec’s Group Medical Plan. On
written instruction from Employee, Veritec shall deduct from Employee’s accrued but unpaid
compensation Employee’s portion of the cost of premiums for direct payment to Veritec’s Group
Medical Plan insurance company. All other issues will be in accordance with the “Veritec
Employee Policy.” Upon termination of this Agreement, payments under this paragraph shall
cease, provided, however, that the Employee shall be entitled to payments for periods or
partial periods that occurred prior to the date of termination and for which the Employee has
not yet been paid.

 

Page 3

Employment Agreement — Jeffrey Hattara

 

	(f)	 	Incentive Compensation Bonus Plan. Employee shall be eligible to participate in any
Incentive Compensation Bonus Plan as may be determined from time to time by the Board of
Directors or any Committee thereof. Employee shall also be eligible to participate in any
other executive level benefit or compensation plan generally applicable to senior executives
of Veritec.

	(g)	 	Vacation — Vacation Compensation. Employee shall be entitled to three (3) weeks of paid
vacation during the first year of employment and entitled to four (4) weeks of paid vacation
during each year of employment, beginning on the first day after completion of one (1) year of
service. Commencing on the first day of employment the Employee’s vacation shall accrue at
the applicable rate during each pay period and shall accrue up to a maximum amount of 200
hours (e.g., 5 weeks).

	(h)	 	Reimbursement of Expenses. During the period of employment the Employee is authorized to
incur necessary and reasonable business expenses in furtherance of Employee’s duties and in
accordance with Veritec’s expense reimbursement policies. Veritec shall reimburse Employee
for all documented and reasonable costs and expenses incurred in furtherance of Veritec’s
business.

2.04. Confidential Information — Intellectual Property — Covenant Not To Compete.

	(a)	 	Employee agrees that all Inventions and Works of Authorship developed by Employee in the
course and scope of his employment are and shall be exclusively owned by Veritec and Employee
hereby assigns to Veritec all right, title and interest, including but not limited to all
intellectual property rights, in and to such Inventions and Works of Authorship.

	(b)	 	Employee agrees that upon the request of Veritec, Employee shall immediately return all
tangible forms of Confidential Information or Veritec Property that may from time to time be
entrusted to Employee.

	(c)	 	Employee hereby agrees not to disclose Veritec Confidential Information to any third party
without Veritec’s prior express written consent. Employee agrees and shall hold in confidence
any and all Confidential Information owned by Veritec. Employee agrees not to use Veritec’s
Confidential Information for any purpose other than the performance of services to be
performed for the exclusive benefit of Veritec under the terms and conditions of this
Agreement. Employee will protect the Confidential Information disclosed by Veritec and shall
insure that the provisions of this paragraph are made binding upon any third party employed,
retained or contracted with by Employee, whom Employee’s disclosure is authorized by Veritec.
A violation by Employee of this paragraph together with the threatened violation of this
paragraph, shall be a material breach of this Agreement and will be a basis for Veritec to
terminate this Agreement for cause.

	(d)	 	Employee agrees that the confidentiality provisions of this Agreement shall remain in full
force and effect and shall survive the expiration or termination hereof.

In recognition that Veritec’s Confidential Information and the services of Employee hereunder
are special and unique assets of Veritec, Employee promises, covenants, warrants and agrees
that for one (1) year following the expiration or termination of this Agreement, that Employee
shall not directly or indirectly: (1) become employed or engaged in any form of Competitive
Business with Veritec’s business; (2) provide assistance to any third party for their direct
or indirect conducting of a Competitive Business to the business of Veritec; or (3) solicit,
induce or encourage any employee, independent contractor or consultant of or to
Veritec to terminate such person’s employment or other relationship with Veritec. A violation
or threatened violation by Employee of this paragraph shall be a material breach of this
Agreement and will be a basis for Veritec to seek any and all remedies provided by law or at
equity.

 

Page 4

Employment Agreement — Jeffrey Hattara

 

2.05. Term and Termination. The term of this Agreement shall commence upon the Effective
Date and shall terminate upon the death, permanent disability or termination of Employee’s
employment on not less than thirty (30) days written notice from either Employer or Employee. If
Employer terminates Employee’s employment without cause, Employee shall be paid as a severance
benefit Employee’s base salary and benefits for a twelve (12) month period after the date of
separation of employment from Veritec. “Cause” as used in this Agreement shall mean the following:

	(a)	 	Employee commits an act of dishonesty or fraud that is of a material nature and involves a
material breach of trust with respect to the interests of Veritec;

	(b)	 	Employee’s refusal or failure to perform Employee’s duties and responsibilities that is not
cured to Veritec’s sole, reasonable satisfaction within ten (10) days written notice by
Veritec, or such other period of time as seems reasonable in given the circumstances;

	(c)	 	Employee commits a material breach of any agreement between Employee and Veritec and the
Employee fails to cure such breach within thirty (30) days of receiving written notice thereof
by Veritec; or

	(d)	 	Employee engages in conduct punishable as a felony or gross misdemeanor, or conduct involving
moral turpitude.

Upon termination of this Agreement for any reason, Employee shall have the right to continue
medical coverage only to the extent required by applicable law.

2.06. Compliance with Rules. Employee agrees to comply with all lawful rules and policies
promulgated by Veritec and made known to Employee, whether such rules and policies are contained in
Veritec’s Employee Manual or otherwise disseminated in writing hereafter.

2.07. Return of Veritec Property. Upon termination of this Agreement, Employee shall
deliver all Veritec property of any nature and kind, including but not limited to: keys, credit
cards, vehicles, records, notes, data, diagrams, drawings, memoranda, models, computers, equipment
and computer software, that shall be in Employee’s possession or under Employee’s control.

2.08. Indemnification. Employee shall be indemnified by Veritec for all liability or
damages incurred within the scope of his employment as provided by applicable law, and Employer
shall obtain and maintain an Officers and Directors insurance policy which covers Employee.

III.

General Terms

3.01. Employer/Employee Relationship Only. Nothing in this Agreement is intended or shall
be deemed to constitute the creation of a partnership, agency, joint venture, or any form legal
relationship between Veritec and Employee other than that of an employment relationship.

3.02. Notices. Any notice required or permitted to be given under this Agreement shall be
given in writing and shall be hand delivered or sent via express carrier, registered or certified mail to
Veritec at its principal place of business (attention “President”) or to Employee at his then
current residence address. Notice shall be deemed given upon actual receipt.

 

Page 5

Employment Agreement — Jeffrey Hattara

 

3.03. Entire Agreement. This Agreement sets forth the entire understanding between The
Parties as to the subject matter hereof and supersedes all prior and contemporaneous agreements,
representations and understandings relating to such subject matter.

3.04. Modifications. Course of conduct and oral communications shall not be taken into
account in determining if The Parties have modified a term or condition hereof. Amendments to this
Agreement shall be invalid unless made in writing duly executed by The Parties hereto.

3.05. Choice of Law / Arbitration. This Agreement is acknowledged to have been made in
and shall be construed in accordance with the applicable laws of the state of Minnesota and those
of the United States of America, without regard to the conflict of laws provisions of such
governing law. If there is any dispute between the parties regarding any provision of this
Agreement, any controversy or claim arising out of or relating to this contract, or the breach
thereof, shall be settled by arbitration in accordance with the Employment Arbitration Rules of the
American Arbitration Association, and judgment upon the award rendered by the arbitrator(s) may be
entered in any Court having jurisdiction thereof. Such arbitration shall be conducted in the Twin
Cities, State of Minnesota, and Veritec shall pay the cost of arbitration unless the arbitration
panel determines that the Employee has acted wantonly, recklessly or without due regarding to
Veritec’s rights.

3.06. Survivability. Should a term or condition set forth herein be deemed to be void as
against public policy or otherwise unconscionable, such term or condition shall be stricken from
this Agreement and the remainder hereof shall be read to affect the intent of The Parties.

3.07. Waiver. The failure of either Party to enforce any provision of this Agreement
shall not be construed as a waiver or limitation of that Party’s right to subsequently enforce and
compel strict compliance with every provision of this Agreement.

3.08. Headings. Headings to paragraphs and Sections herein have no significance or
meaning and are for purposes of convenience of reference only.

3.09. Counterparts. This Agreement may be executed in one or more counterparts (including
by means of facsimile), each of which shall be deemed an original but all of which together will
constitute one and the same instrument.

3.10. Authorization. The Parties hereby certify one to the other, that they have the
legal capacity to execute this Agreement and to become bound by the terms and conditions hereof.

3.11. Successors. This Agreement shall be binding upon any successor (whether direct or
indirect and whether by purchase, merger, consolidation or otherwise) to all or substantially all
of Veritec’s business or assets. This Agreement and all rights of the Employee hereunder shall
inure to the benefit of, and be enforceable by, the Employee’s personal or legal representatives,
executors, administrators, heirs, distributes, devisees and legatees.

[THE NEXT PAGE IS THE SIGNATURE PAGE]

 

Page 6

Employment Agreement — Jeffrey Hattara

 

IN WITNESS WHEREOF, The Parties hereby cause this Agreement to become binding upon them on the
Effective Date hereof.

	 	 	 	 	 
	Veritec, Inc.

	 	 
	 
	 	 	 	 
	By:

	 	/s/ Van Tran
 

	 	 
	 

	 	Van Tran, Executive Chairman	 	 
	 
	 	 	 	 
	 

	 	Jeffrey Hattara	 	 
	 
	 	 	 	 
	 

	 	/s/ Jeffrey Hattara
 

	 	 

 

Page 7

Employment Agreement — Jeffrey Hattara

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00163-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00163-of-00352.parquet"}]]